| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.004 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |